Administration of Astragalus Membranaceus prevented kidney dysfunction in cisplatin-AKI model mice
Administration of Astragalus Membranaceus prevented kidney dysfunction in cisplatin-AKI model mice
复制标题
服用黄芪可预防顺铂 AKI 模型小鼠的肾功能障碍
DOI:
10.1093/ndt/gfz106.fp292
复制
发表时间:
2019
影响因子:
6.1
通讯作者:
Kinoue Takaaki
中科院分区:
文献类型:
--
作者:
Kagemasa Kajiwara;Arai Makoto;Nakada Yoshinobu;Kinoue Takaaki
METHODS: The left renal pedicle of adult male mice was clamped for 60 min, and reperfusion and right nephrectomy were performed immediately. Separate groups were administered anti-RANKL antibody and recombinant RANKL 24 h before surgery. After reperfusion for a set period of time, the serum creatinine level was measured, and the left kidney was removed. Histological examination and western blotting of the left kidney were performed to evaluate the expression and localization of the RANKLRANK system and proteins related to I/R. RESULTS:Serum creatinine levels were significantly elevated by I/R injury. A time-dependent increase of RANKL was observed up to 24 h, whereas RANK was induced until 12 h after reperfusion. RANK was expressed in infiltrating inflammatory cells, which were positive for CD68, a marker of monocytes/macrophages. Anti-RANKL antibody significantly impaired renal function and increased the induction inflammatory cytokines compared with those of the I/R group. However, recombinant RANKL significantly improved renal function and decreased the induction of inflammatory cytokines compared with those of the I/R group. CONCLUSIONS: The present study is the first to evaluate the role of the RANKLRANK system in renal I/R injury. RANKL-RANK signalling inhibits inflammatory cytokines by affecting macrophage function and leads to improved renal function following I/R injury.